Evergreen Wealth Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.24M Buy
20,908
+634
+3% +$136K 0.27% 65
2026
Q1
$4.41M Buy
20,274
+10,210
+101% +$2.26M 0.31% 62
2025
Q4
$2.3M Buy
10,064
+6,439
+178% +$1.47M 0.32% 45
2025
Q3
$839K Sell
3,625
-422
-10% -$85.9K 0.47% 43
2025
Q2
$751K Buy
4,047
+416
+11% +$77.3K 0.45% 43
2025
Q1
$761K Sell
3,631
-232
-6% -$45.1K 0.51% 37
2024
Q4
$687K Buy
3,863
+73
+2% +$13.4K 0.48% 41
2024
Q3
$749K Sell
3,790
-994
-21% -$186K 0.51% 35
2024
Q2
$821K Buy
+4,784
New +$792K 0.58% 33
2022
Q3
– Sell
-1,309
Closed -$200K – 94
2022
Q2
$200K Buy
+1,309
New +$200K 0.25% 96

Other funds holding ABBV

Evergreen Wealth Solutions's ABBV Position: Q2 2026 in Review

Evergreen Wealth Solutions increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $136K and bringing the position to 20,908 shares worth $5.24M. The position accounts for 0.27% of the portfolio, ranked #65.

Evergreen Wealth Solutions first reported a position in ABBV in Q2 2022 and has held it in 10 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Evergreen Wealth Solutions held 20,908 shares of AbbVie worth $5.24M as of Q2 2026.
  • Evergreen Wealth Solutions bought 634 AbbVie shares in Q2 2026, an estimated $136K.
  • AbbVie made up 0.27% of Evergreen Wealth Solutions's portfolio in Q2 2026, its #65 holding.
  • Evergreen Wealth Solutions first reported a position in AbbVie in Q2 2022 and has held it in 10 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Evergreen Wealth Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.